TABLE 5.
Contrast-associated acute kidney injury.
| References | CA-AKI definition | Proportion of cases with CA-AKI (%) |
CA-AKI Absolute risk reduction (%) (95% CI) |
Relative risk of a CA-AKI event (95% CI) |
|
| DyeVert group (95% CI) |
Control group (95% CI) |
||||
| Briguori et al. (30) | SCr ↑ ≥ 0.3 mg/dL within 72 h | 8.00 (3.33–15.65) |
19.00 (11.50–28.64) |
11.00 (−3.73 to 25.73) |
0.42 (0.18–0.95) |
| Kutschman et al. (33) | SCr ↑ ≥ 0.3 mg/dL or 50% within 48 h | 6.90 (4.13–10.71) |
10.30 (6.78–14.83) |
3.00 (−5.78 to 11.78) |
0.67 (0.37–1.20) |
| Sattar et al. (31) | SCr ↑ ≥ 0.3 mg/dL or 50% | 12.20 (4.08–26.20) |
16.21 (8.38–27.14) |
4.00 (−15.04 to 23.04) |
0.75 (0.28–2.01) |
| Bunney et al. (34) | SCr ↑ ≥ 0.3 mg/dL or 50% within 48 h | 3.45 (0.09–17.76) |
9.35 (7.39–11.63) |
6.00 (−0.95 to 12.95) |
0.37 (0.05–2.56) |
| Tajti et al. (35) | NR | 2.56 (0.06–13.48) |
2.20 (0.27–7.72) |
−0.4.00 (−2.00 to 2.20) |
1.17 (0.11–12.5) |
| Pooled | 7.30 (5.11–9.85) |
10.65 (6.60–15.52) |
5.00 (0.40 to 9.80) |
0.60 (0.40–0.90) |
|
CA-AKI, contrast-associated acute kidney injury; CI, confidence interval; NR, not reported; SCr, serum creatinine.